Close Menu

NEW YORK (GenomeWeb) – With novel amplification and detection technology, startup Prominex promises fully-automated multiplex molecular point-of-care testing that can provide results in five minutes.

The firm recently raised $4 million in Series A-1 funding and is driving towards launching a sample-in, results-out, CLIA-waived instrument and infectious disease assays in the next three years for an intended market of hospitals, emergency departments, intensive care units, and physician offices.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.